Fishers, IN, United States of America

Yao-Chang Xu

USPTO Granted Patents = 31 



Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 128(Granted Patents)


Company Filing History:


Years Active: 1998-2014

Loading Chart...
Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Yao-Chang Xu: A Pioneer in Migraine Treatment Innovations

Introduction

Yao-Chang Xu, based in Fishers, Indiana, is a prolific inventor with an impressive portfolio of 31 patents. His work primarily revolves around innovative compounds aimed at treating neurological conditions, particularly migraine.

Latest Patents

Among his latest inventions, Yao-Chang Xu has developed compounds of formula I, which are associated with activating 5-HT receptors and inhibiting neuronal protein extravasation. These compounds are particularly significant in the treatment or prevention of migraines in mammals. He has also outlined a process for synthesizing intermediates essential for the production of these compounds, showcasing his contribution to the pharmaceutical field.

Career Highlights

Yao-Chang Xu has made notable strides in his professional journey, having worked with prestigious organizations such as Eli Lilly and Company and Avera Pharmaceuticals, Inc. His tenure at these companies underscores his commitment to advancing pharmaceutical research and development.

Collaborations

Throughout his career, Yao-Chang Xu has collaborated with esteemed colleagues, including Daniel Timothy Kohlman and Sidney Xi Liang. These partnerships have played a vital role in the development of various innovative solutions in the medical field.

Conclusion

Yao-Chang Xu stands out as a significant figure in the realm of innovations aimed at treating migraines. His extensive experience and collaborative efforts contribute to the evolving landscape of pharmaceutical research, making him a key inventor to watch in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…